The 2026 International Update & Breakthrough Symposium on Pediatric Hematology/Oncology serves as an international platform for healthcare professionals, researchers, and trainees to exchange knowledge and explore the latest advances in pediatric hematology and oncology. Through keynote lectures, scientific updates, and academic discussions, the symposium aims to foster international collaboration, promote innovation, and advance the care of children and adolescents with hematologic and oncologic diseases.

We are honored to welcome distinguished experts from internationally renowned medical centers and research institutions, including Dr. Keita Terashima, Dr. Jason Cheng-Hsuan Chiang, Dr. Ayumu Arakawa, Dr. David Chung-Chuan Shyr, and Dr. Tami D. John, together with leading specialists from Taiwan. These experts will share their clinical expertise, research achievements, and perspectives on emerging developments in the field.

The scientific program encompasses a wide range of topics, including pediatric brain tumors, novel therapeutic approaches, pediatric cancer drug development, hematopoietic stem cell transplantation, gene therapies for inherited blood disorders, and updates from international conferences and multicenter collaborative study groups. By bringing together experts from diverse disciplines and institutions, the symposium seeks to strengthen academic exchange, inspire future collaborations, and contribute to continued progress in pediatric hematology and oncology worldwide.